CSIMarket Company Name, Ticker, Customers, else..
 
Regenerx Biopharmaceuticals inc   (NONE: RGRX)
Other Ticker:  
 
 
Price: $0.0002 $0.00 0.000%
Day's High: $0.0002 Week Perf: -85.71 %
Day's Low: $ 0.00 30 Day Perf: -85.71 %
Volume (M): 0 52 Wk High: $ 0.06
Volume (M$): $ 0 52 Wk Avg: $0.01
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 144
 Employees 6
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -2
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 0

Regenerx Biopharmaceuticals Inc
Regenerx Biopharmaceuticals Inc is a biotechnology company that focuses on developing innovative therapies for the treatment of various medical conditions. The company's primary focus is on developing regenerative medicine products, particularly therapeutic protein formulations, to promote tissue and organ repair. Regenerx Biopharmaceuticals aims to provide novel treatment options for patients suffering from diseases or injuries that currently have limited therapeutic options. The company conducts extensive research and development to discover and develop new drug candidates, with a particular emphasis on promoting tissue and organ regeneration.


   Company Address: 15245 Shady Grove Road ? Suite 470 Rockville 20850 MD
   Company Phone Number: 208-9191   Stock Exchange / Ticker: NONE RGRX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
JNJ        3.78% 
LLY        14.68% 
MRK   -1.49%    
TEVA        3.82% 
VRTX        3.97% 
VTRS        3.65% 
• View Complete Report
   



Regenerx Biopharmaceuticals Inc

Regenerx Biopharmaceuticals Inc Reports Flat EPS Despite Modest Revenue Decrease

Regenerx Biopharmaceuticals Inc, a leading biopharmaceutical company, recently announced its financial report for the most recent fiscal period. According to the report, the company's earnings per share (EPS) remained at $0.00 despite a modest revenue reduction. The revenue for the year decreased by -0.005% to $0.02 million from the previous year.
However, from the previous reporting period, Regenerx Biopharmaceuticals Inc saw an increase in revenue by 0.005% from $0.02 million, and the EPS remained unchanged from $0.00 per share. This shows a positive sign for the company and its shareholders.









Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com